Posted 15 August, 2023
Ocugen, Inc. appointed new CEO
CEO Change detected for ticker Nasdaq:OCGN in a 8-K filed on 15 August, 2023.
On August 15, 2023, the Company's Board of Directors appointed Shankar Musunuri, Ph.D., MBA, the Company's Chairman, Chief Executive Officer & Co-Founder, as the interim principal financial officer, effective immediately, in light of Mr. Vu's departure.
Don't how to trade CEO change? Read Reasons for CEO Turnover and Effect on Stock Performance.
Overview of Ocugen, Inc.
Relevant filing section
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Effective August 14, 2023, Quan Vu is no longer serving as the Chief Financial Officer/Chief Business Officer, and as principal financial officer and principal accounting officer, of Ocugen, Inc. The separation from employment is being treated as a severance qualifying event under Mr. Vu's employment agreement. On August 15, 2023, the Company's Board of Directors appointed Shankar Musunuri, Ph.D., MBA, the Company's Chairman, Chief Executive Officer & Co-Founder, as the interim principal financial officer, effective immediately, in light of Mr. Vu's departure.
Interested in special situations?
Join Tickerverse
- customize event filters
- create watchlists, bookmarks
- get email notifications for the latest special situations
- browse and analyze public companies, executives and SEC filings
Tickerverse is a great way to find investment opportunities in corporate actions.
By signing up you agree to our Terms of Service and Privacy Policy.